science top stories popular news  

Daily non-political popular news in brief.

Other highlights in the November 1 JNCI

10-31-2006 · EurekAlert!

Other highlights in the November 1 issue of JNCI include a review of statins and fibrates for action against melanoma, a study of a virus that kills brain tumors in mice, an antibody that decreases ovarian cancer growth in mice and a study that describes the use of the immunohistochemical assay in predicting clinical trial results for breast cancer patients.

Read more »

Keywords: highlights, november, jnci, highlight

« Previous | Next »

Similar news on "Other highlights in the November 1 JNCI":

  1. Other highlights in the November 15 JNCI
    11-14-2006 · EurekAlert!
    Other highlights in the Nov. 15 JNCI include the impact of weight on colon cancer outcomes, a combination therapy that increases ovarian cancer survival, impact of aging on breast cancer risk and a molecule that can target the tumor vascular system.
    Similar news · Read more »
  2. Newsbriefs from the journal Chest, November 2006
    11-13-2006 · EurekAlert!
    Newsbriefs from the November issue of the journal Chest highlight studies related to the link between HIV and COPD, the use of vitamin A for emphysema and how patients stay in control of their asthma.
    Similar news · Read more »
  3. Other highlights in the April 4 JNCI
    04-03-2007 · EurekAlert!
    Also in the April 4 JNCI are a study on the risk of noncancer death among testicular cancer survivors, a report that celecoxib does not prevent cancer in Barrett's esophagus patients, and a link between bladder cancer and androgens in mice.
    Similar news · Read more »
  4. Other highlights from the June 6 JNCI
    06-05-2007 · EurekAlert!
    Also in the June 6 JNCI is an association between aspirin use and decreased risk of cancer, a protein that suppresses tumor growth and cell migration, the incidence of a rare cancer in Denmark, and a protein that is not associated with inflammation, but not breast cancer.
    Similar news · Read more »
  5. Other highlights in the May 2 JNCI
    05-01-2007 · EurekAlert!
    Also in the May 2 JNCI is a follow-up to the Italian Randomized Tamoxifen Trial, a study on treating breast cancer patients with three HER inhibitor drugs, an increase in survival rates for indolent lymphoma patients using a chemotherapy-rituximab combination, and new lung cancer risk prediction models.
    Similar news · Read more »
  6. Other highlights in the Oct. 30 JNCI
    10-30-2007 · EurekAlert!
    Also in the Oct. 30 JNCI -- a cancer-killing virus that may be used to treat metastatic cancer, the risk of second cancers in cervical cancer survivors, a novel trial design that shows which cancer treatments are the most promising, and a review on brain cancer therapies that target normal brain cells too.
    Similar news · Read more »
  7. Other highlights in the Dec. 11 JNCI
    12-11-2007 · EurekAlert!
    Also in the Dec. 11 JNCI are a drug that may reduce breast cancer recurrence, the risk of cancer after a blood transfusion, the association between PSA testing and prostate cancer diagnoses, and cancer risk among NBN mutation carriers.
    Similar news · Read more »
  8. Highlights from the November 2006 Journal of the American Dietetic Association
    11-01-2006 · EurekAlert!
    The November 2006 issue of the Journal of the American Dietetic Association contains articles and research studies you may find of interest. Below is a summary of some of this month's articles.
    Similar news · Read more »
  9. Other highlights in the March 7 JNCI
    03-06-2007 · EurekAlert!
    Other highlights in the March 7 JNCI include a study showing how changes in breast density affect breast cancer risk, a new potential treatment for prostate cancer, a gene that influences the formation of benign bone tumors, and an essay on the additional health benefits of breast cancer prevention drugs.
    Similar news · Read more »
  10. Other highlights from the July 10 JNCI
    07-10-2007 · EurekAlert!
    Also in the July 10 JNCI are studies on a "nanobubble" drug delivery method, a gene that may promote chemotherapy drug resistance, and an association between vitamin D and reduced colon cancer risk.
    Similar news · Read more »